Call for abstracts
- February 1: Call for abstracts opens
- April 14: Call for abstracts closes
- May 8: Notification of abstract decision
Submission types
Short talk
10-15 min talk, focused on a package, an application note, or a current research presentation. Presentations seeking collaboration or input from the community are encouraged.
Presenters are encouraged to submit their slides to the Bioconductor EuroBioC2023 conference gateway on F1000Research. The submission is free, and published slides on F1000Research will receive a digital object identifier (DOI). For more details, please refer to the Poster & Slides Guidelines. Inclusion of the Bioconductor logo and/or #EuroBioC2023 tag is encouraged.
Software demo (“short workshop”)
30-45 min demonstration of a software package or workflow.
Poster
Classical poster printed on paper to be stuck to a wall, approximate size DIN A0.
Poster presenters are encouraged to submit their poster to the Bioconductor EuroBioC2023 conference gateway on F1000Research. The submission is free, and published posters on F1000Research will receive a digital object identifier (DOI). For more details, please refer to the Poster & Slides Guidelines. Inclusion of the Bioconductor logo and/or #EuroBioC2023 tag is encouraged.
Contributed session
Dedicated session consisting of 2-3 talks (10-15 min each) and a 10-15 min discussion by the session chair(s). To propose a contributed session, all the intended talks must be submitted separately by the respective presenter (as regular short talk submissions) to OpenReview, and in addition a proposal for the contributed session must be submitted by the session chair(s), providing a brief description and listing the talks that would take part in the session.
Birds-of-a-feather session
Free-format, organizer-lead interactive discussion session on a topic relevant to the Bioconductor community. The submission of Birds-of-a-feather sessions will take place on GitHub, and the call will be open beyond the submission deadline of the other submission types. More information will be provided here shortly.